Skip to main content
Article thumbnail
Location of Repository

Inhibition of Phosphatidylserine Recognition Heightens the Immunogenicity of Irradiated Lymphoma Cells In Vivo

By Attilio Bondanza, Valérie S. Zimmermann, Patrizia Rovere-Querini, Javier Turnay, Ingrid E. Dumitriu, Christian M. Stach, Reinhard E. Voll, Udo S. Gaipl, Wolf Bertling, Ernst Pöschl, Joachim R. Kalden, Angelo A. Manfredi and Martin Herrmann

Abstract

Strategies to enhance the immunogenicity of tumors are urgently needed. Although vaccination with irradiated dying lymphoma cells recruits a tumor-specific immune response, its efficiency as immunogen is poor. Annexin V (AxV) binds with high affinity to phosphatidylserine on the surface of apoptotic and necrotic cells and thereby impairs their uptake by macrophages. Here, we report that AxV preferentially targets irradiated lymphoma cells to CD8+ dendritic cells for in vivo clearance, elicits the release of proinflammatory cytokines and dramatically enhances the protection elicited against the tumor. The response was endowed with both memory, because protected animals rejected living lymphoma cells after 72 d, and specificity, because vaccinated animals failed to reject unrelated neoplasms. Finally, AxV–coupled irradiated cells induced the regression of growing tumors. These data indicate that endogenous adjuvants that bind to dying tumor cells can be exploited to target tumors for immune rejection

Topics: Article
Publisher: The Rockefeller University Press
OAI identifier: oai:pubmedcentral.nih.gov:2211859
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2000). A receptor for phosphatidylserine-specific clearance of apoptotic cells.
    2. (2002). Antigen presentation by dendritic cells in vivo.
    3. (2001). Apoptotic cells overexpress vinculin and induce vinculin-specific cytotoxic T-cell cross-priming.
    4. (2001). C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells.
    5. (2000). CD8( ) but not CD8( ) dendritic cells cross-prime cytotoxic T cells in vivo.
    6. (2003). Cell biology. Eat me or die.
    7. (2003). Cell corpse engulfment mediated by C. elegans phosphatidylserine receptor through CED-5 and CED-
    8. (2002). Cell death releases endogenous adjuvants that selectively enhance immune surveillance of particulate antigens.
    9. (2003). Characterisation of functional biotinylated TNFalpha targeted to the membrane of apoptotic melanoma cells.
    10. (1995). Collagen binding activity of recombinant and N-terminally modified annexin V (anchorin CII).
    11. (2002). Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node.
    12. (2002). Cross-presentation of cellassociated antigens by CD8alpha dendritic cells is attributable to their ability to internalize dead cells.
    13. (2004). Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens.
    14. (1976). Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay.
    15. (2004). Cutting edge: conventional CD8 alpha dendritic cells are generally involved in priming CTL immunity to viruses.
    16. (1998). Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs.
    17. (2001). Dendritic cells resurrect antigens from dead cells. Trends Immunol.
    18. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells.
    19. (1999). Engulfment of apoptotic cells involves the redistribution of membrane phosphatidylserine on phagocyte and prey.
    20. (2003). Epidermal viral immunity induced by CD8alpha dendritic cells but not by Langerhans cells.
    21. (1999). Exposure of phosphatidylserine is a general feature in the phagocytosis of apoptotic lymphocytes by macrophages. Cell Death Differ.
    22. (2004). HMGB1 is an endogenous immune adjuvant released by necrotic cells.
    23. (1998). Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies.
    24. (1998). Immature dendritic cells phagocytose apoptotic cells via v 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes.
    25. (2002). Immune tolerance after delivery of dying dells to dendritic dells in situ.
    26. (1999). Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokines.
    27. (1999). Inducing autoimmune disease to treat cancer.
    28. (1998). Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.
    29. (2002). Major histocompatibility complex class II presentation of cell-associated antigen is mediated by CD8 dendritic cells in vivo.
    30. (2004). MHC class II expression restricted to CD8 and CD11b dendritic cells is sufficient for control of Leishmania major.
    31. (2003). Molecular identification of a danger signal that alerts the immune system to dying cells.
    32. (2003). Origin, precursors and differentiation of mouse dendritic cells.
    33. (2001). Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences.
    34. (2001). Phagocytosis and clearance of apoptotic cells is mediated by MER.
    35. (2001). Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells.
    36. (2003). Phosphatidylserine expression and phagocytosis of apoptotic thymocytes during differentiation of monocytic cells.
    37. (2003). Phosphatidylserine receptor is required for clearance of apoptotic cells.
    38. Processing of engulfed apoptotic bodies yields T cell epitopes.
    39. (1999). Regulation of phosphatidylserine exposure and phagocytosis of apoptotic T lymphocytes. Cell Death Differ.
    40. (2000). Surface expression of phosphatidylserine on macrophages is required for phagocytosis of apoptotic thymocytes. Cell Death Differ.
    41. (2001). Tethering and tickling: a new role for the phosphatidylserine receptor.
    42. (2002). The CD8 dendritic cell subset selectively endocytoses dying cells in culture and in vivo.
    43. (2003). The final step in programmed cell death: phagocytes carry apoptotic cells to the grave. Essays Biochem.
    44. (2004). TNF-alpha coupled to membrane of apoptotic cells favors the crosspriming to melanoma antigens.
    45. (2003). Tolerogenic dendritic cells.
    46. (2000). Treatment with annexin V increases immunogenicity of apoptotic human T-cells in Balb/c mice. Cell Death Differ.
    47. (2002). Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and crosspriming of CD8( ) T cells produce active immune unresponsiveness.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.